Erector spinae plane block for reduction of early postoperative pain scores and opioid use in lumbar spinal fusion surgery, a prospective double-blinded randomized placebo controlled trial - RCT-ESPB

Sint Maartenskliniek0 个研究点目标入组 76 人2021年11月17日

概览

阶段: 1 期
干预措施: 未指定
疾病 / 适应症: Patients planned to undergo elective lumbar spinal fusion surgery with a dorsal surgical approach
发起方: Sint Maartenskliniek
入组人数: 76
状态: 进行中（未招募）
最后更新: 4年前

暂无简介。

注册库

who.int

开始日期

2021年11月17日

结束日期

待定

最后更新

4年前

研究类型

Interventional clinical trial of medicinal product

性别

All

发起方

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•\- Age \= 18 years;
•\- Patients planned for elective lumbar spinal fusion surgery with a dorsal surgical approach;
•\- 2\-4 level spine fusion surgery;
•\- Written informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1\.2 Adults (18\-64 years) yes
•F.1\.2\.1 Number of subjects for this age range 38
•F.1\.3 Elderly (\>\=65 years) yes

•A Body Mass Index (BMI) \> 40 kg/m²;
•ASA physical health classification \> 3;
•Patients who will undergo spine surgery involving less than 2 or more than 4 levels of fusion, scoliosis surgery;
•Patients who will undergo circumferent spine surgery;
•Patients with an active, local infection or systemic infection;
•Patients with an allergy to one or more medications used in the study;
•Patients with any contraindication to a regional anesthetic technique;
•Kidney\- or liver failure inhibiting the systemic use of paracetamol and/or NSAIDs;
•Acute surgeries;
•Patients with a history of drugs or alcohol abuse;